Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Fuda Cancer Hospital, Guangzhou)"
Count: 116
Selected: 0
NCT IDTitle
NCT03357315Mix Vaccine for Metastatic Sarcoma Patients
NCT03357289Mix Vaccine for Metastatic Kidney Cancer
NCT03357276Mix Vaccine for Metastatic Colorectal Cancer
NCT03183232Safety and Efficiency of γδ T Cell Against Lung Cancer
NCT03183219Safety and Efficiency of γδ T Cell Against Liver Cancer
NCT03183206Safety and Efficiency of γδ T Cell Against Breast Cancer
NCT03180437Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer
NCT02425748Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)
NCT02425735Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer
NCT02418481Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)
NCT03985462Very Small Embryonic-like Stem Cells for Ovary
NCT03976206Very Small Embryonic-like Stem Cells for Facial Skin Antiaging
NCT03975101Very Small Embryonic-like Stem Cells for Knee Osteoarthritis
NCT03973021Very Small Embryonic-like Stem Cells for Erectile Dysfunction
NCT04406610CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients
NCT04393220Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma
NCT03818347Hydrogen Gas for Cancer Rehabilitation
NCT03673137Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC
NCT03554395Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Gastric Cancer
NCT03540199Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer
NCT03524274Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer
NCT03524261Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer
NCT03509298Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer
NCT03501056Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer
NCT03484962Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer
NCT03350490Bioinformation Therapy for Intestinal Cancer
NCT03350477Bioinformation Therapy for Gastric Cancer
NCT03338543PENS or TENS for Pain in Liver Cancer
NCT03331055PENS or TENS for Pain in Pancreatic Cancer
NCT03252171CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients
NCT03240224Bioinformation Therapy for Breast Cancer
NCT03239184Bioinformation Therapy for Pancreatic Cancer
NCT03239171Bioinformation Therapy for Lung Cancer
NCT03239158Bioinformation Therapy for Liver Cancer
NCT03008499High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer
NCT03008343Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer
NCT03008330High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer
NCT03008304High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer
NCT03007875High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer
NCT03007836High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal Cancer
NCT03007823High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma
NCT02981719Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer
NCT02857920Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors
NCT02853903Comparison of Autogenic and Allogenic NK Immunotherapy on the Outcome of Recurrent Solid Tumors
NCT02849379Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer
NCT02849366Combination of Cryosurgery and NK Immunotherapy for Recurrent Sarcoma
NCT02849353Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer
NCT02849340Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer
NCT02849327Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer
NCT02849314Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer